Long-Term Follow-Up of the Randomized (BIOMArCS-2) Glucose Trial: Intensive Glucose Regulation in Hyperglycemic Acute Coronary Syndrome.
From Netherlands Heart Institute, Utrecht (V.J.v.d.B.); Department of Cardiology, Noordwest Ziekenhuisgroep, Alkmaar, the Netherlands (V.J.v.d.B., V.A.W.M.U., F.S., J.H.C.); and Department of Cardiology, Erasmus Medical Center, Rotterdam, the Netherlands (V.J.v.d.B., M.d.M., K.M.A., I.K., E.B.).
Victor J
VJ
van den Berg
From Netherlands Heart Institute, Utrecht (V.J.v.d.B.); Department of Cardiology, Noordwest Ziekenhuisgroep, Alkmaar, the Netherlands (V.J.v.d.B., V.A.W.M.U., F.S., J.H.C.); and Department of Cardiology, Erasmus Medical Center, Rotterdam, the Netherlands (V.J.v.d.B., M.d.M., K.M.A., I.K., E.B.). v.a.w.m.umans@nwz.nl.
Victor A W M
VA
Umans
From Netherlands Heart Institute, Utrecht (V.J.v.d.B.); Department of Cardiology, Noordwest Ziekenhuisgroep, Alkmaar, the Netherlands (V.J.v.d.B., V.A.W.M.U., F.S., J.H.C.); and Department of Cardiology, Erasmus Medical Center, Rotterdam, the Netherlands (V.J.v.d.B., M.d.M., K.M.A., I.K., E.B.).
Frank
F
Stam
From Netherlands Heart Institute, Utrecht (V.J.v.d.B.); Department of Cardiology, Noordwest Ziekenhuisgroep, Alkmaar, the Netherlands (V.J.v.d.B., V.A.W.M.U., F.S., J.H.C.); and Department of Cardiology, Erasmus Medical Center, Rotterdam, the Netherlands (V.J.v.d.B., M.d.M., K.M.A., I.K., E.B.).
Maarten
M
de Mulder
From Netherlands Heart Institute, Utrecht (V.J.v.d.B.); Department of Cardiology, Noordwest Ziekenhuisgroep, Alkmaar, the Netherlands (V.J.v.d.B., V.A.W.M.U., F.S., J.H.C.); and Department of Cardiology, Erasmus Medical Center, Rotterdam, the Netherlands (V.J.v.d.B., M.d.M., K.M.A., I.K., E.B.).
K Martijn
KM
Akkerhuis
From Netherlands Heart Institute, Utrecht (V.J.v.d.B.); Department of Cardiology, Noordwest Ziekenhuisgroep, Alkmaar, the Netherlands (V.J.v.d.B., V.A.W.M.U., F.S., J.H.C.); and Department of Cardiology, Erasmus Medical Center, Rotterdam, the Netherlands (V.J.v.d.B., M.d.M., K.M.A., I.K., E.B.).
Jan H
JH
Cornel
From Netherlands Heart Institute, Utrecht (V.J.v.d.B.); Department of Cardiology, Noordwest Ziekenhuisgroep, Alkmaar, the Netherlands (V.J.v.d.B., V.A.W.M.U., F.S., J.H.C.); and Department of Cardiology, Erasmus Medical Center, Rotterdam, the Netherlands (V.J.v.d.B., M.d.M., K.M.A., I.K., E.B.).
Isabella
I
Kardys
From Netherlands Heart Institute, Utrecht (V.J.v.d.B.); Department of Cardiology, Noordwest Ziekenhuisgroep, Alkmaar, the Netherlands (V.J.v.d.B., V.A.W.M.U., F.S., J.H.C.); and Department of Cardiology, Erasmus Medical Center, Rotterdam, the Netherlands (V.J.v.d.B., M.d.M., K.M.A., I.K., E.B.).
Eric
E
Boersma
D054058:Acute Coronary Syndrome / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000401:mortality; D001786:Blood Glucose / Q000378:metabolism*; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006943:Hyperglycemia / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000401:mortality; D007328:Insulin / Q000008:administration & dosage*; D008297:Male; D015996:Survival Rate
D001786:Blood Glucose; D007328:Insulin
follow-up studies; glucose; myocardial infarction; randomized controlled trial